global
recent
decad
wit
grow
disjunct
valley
death
less
broaden
stride
fundament
biomed
research
incommensur
reach
clinic
plumb
work
research
fund
develop
pipelin
recent
chang
structur
govern
fund
new
public
privat
joint
ventur
specialist
undergradu
postgradu
cours
aim
incorpor
pathway
translat
earliest
stage
reflect
shift
number
biomed
research
public
target
translat
concept
increas
exponenti
continu
rise
rapidli
present
day
fuell
avail
new
research
technolog
well
chang
diseas
cost
press
issu
time
growth
excit
space
undoubtedli
continu
despit
recent
advanc
therapeut
control
immun
function
viral
infect
current
therapi
often
challeng
develop
expens
deploy
readili
select
resistanceconf
mutant
shape
hostviru
immunolog
arm
race
temper
forg
deep
time
biodivers
world
increasingli
har
new
biotechnolog
therapeut
simultan
shift
toward
hostori
antivir
therapi
current
underway
clinic
translat
immunolog
special
featur
illustr
strateg
vision
integr
theme
creat
new
effect
econom
robust
antivir
therapi
immunotherapi
realiti
opportun
afford
research
work
chang
world
squar
mind
open
cti
special
featur
outlin
way
issu
may
solv
creativ
leverag
socal
strength
virus
viral
rna
polymeris
revers
transcript
enabl
resist
treatment
confer
extraordinari
genet
divers
howev
exact
process
ultim
restrict
viral
infect
strongli
limit
viru
genom
size
incorpor
new
inform
coin
evolutionari
dilemma
inform
economi
paradox
mani
virus
attempt
resolv
manipul
multifunct
multitask
host
cell
protein
mmhp
therebi
maximis
host
subvers
viral
infect
minim
inform
cost
argu
expos
achil
heel
may
safe
target
via
hostori
therapi
impos
devast
inform
fit
barrier
escap
mutant
select
furthermor
sinc
mmhp
often
conserv
target
within
viru
famili
mmhptarget
therapi
may
exhibit
robust
broadspectrum
antivir
efficaci
achiev
drug
repurpos
break
viciou
cycl
escal
therapeut
develop
cost
trivial
escap
mutant
select
quickli
multipl
place
also
discuss
altern
posttransl
rnabas
antivir
approach
design
vaccin
immunotherapi
emerg
field
neovirolog
anticip
intern
effort
area
come
decad
enabl
tap
use
new
biolog
function
process
method
control
infect
deploy
symbiot
subclin
virus
new
therapi
biotechnolog
crucial
need
upon
infect
pathogen
stimul
express
numer
host
inflammatori
factor
support
recruit
activ
immun
cell
flip
side
process
also
caus
immunopatholog
prolong
deregul
contribut
special
featur
yoshinaga
takeuchi
review
endogen
rnabind
protein
rbp
posttranscript
control
express
crucial
inflammatori
factor
variou
tissu
potenti
therapeut
applic
rbp
includ
tristetraprolin
promot
degrad
aurich
element
contain
mrna
member
roquin
regnas
famili
respect
promot
effect
degrad
mrna
harbour
stemloop
structur
increasingli
appar
role
rna
methyl
machineri
control
inflammatori
mrna
stabil
activ
take
place
variou
subcellular
compart
differenti
regul
infect
way
mrnadestabilis
rbp
constitut
brake
immun
system
may
ultim
toggl
therapeut
anticip
continu
effort
area
lead
new
method
regain
control
inflamm
autoimmun
select
enhanc
immun
immunotherapi
modul
rna
synthesi
viru
replic
infect
anoth
mrna
posttranscript
regul
roquin
furin
encod
conserv
proprotein
convertas
crucial
human
health
diseas
furin
along
pcsk
famili
member
wide
implic
immun
regul
cancer
entri
matur
releas
broad
array
evolutionarili
divers
virus
includ
human
papillomaviru
hpv
influenza
iav
ebola
ebov
dengu
denv
human
immunodefici
viru
hiv
braun
sauter
review
role
furin
process
well
histori
futur
furintarget
therapeut
also
discuss
recent
work
reveal
two
ifncinduc
factor
exhibit
broadspectrum
inhibit
iav
measl
mv
zika
zikv
hiv
suppress
furin
activ
come
decad
expect
see
everfin
spatiotempor
resolut
hostori
therapi
achiev
safe
effect
broadspectrum
yet
costeffect
therapi
clinic
use
increas
abund
afford
sensit
highthroughput
genom
sequenc
technolog
led
recent
boom
metagenom
catalogu
microbiom
world
minion
nanopor
sequenc
one
latest
innov
space
enabl
direct
sequenc
miniatur
form
factor
minim
sampl
prepar
consumergrad
laptop
comput
nakagawa
colleagu
report
latest
experi
use
system
improv
perform
use
resourcepoor
context
mening
diagnos
direct
sequenc
viral
genom
rna
challeng
system
recent
use
directli
sequenc
rna
viru
genom
iav
first
time
anticip
improv
perform
devic
come
decad
transform
viru
surveil
effort
import
underscor
recent
ebov
novel
coronaviru
ncov
outbreak
enabl
rapid
deploy
antivir
treatment
take
resistanceconf
mutat
account
decad
basic
immunolog
research
provid
nearcomplet
pictur
main
armament
human
antivir
arsen
nevertheless
focu
mammalian
defenc
patholog
sidelin
examin
type
role
virus
antivir
defenc
exist
throughout
biospher
one
case
point
crisprca
antivir
immun
system
prokaryot
repurpos
revolutionari
geneedit
biotechnolog
plant
anim
anoth
ancient
lineag
nucleocytosol
larg
dna
virus
ncldv
emerg
human
pathogen
possess
enorm
genom
sever
megabas
size
encod
hundr
protein
uniqu
unknown
function
moreov
hundr
humanand
avianinfect
virus
iav
strain
known
recent
effort
indic
true
number
may
million
mani
harbour
zoonot
potenti
increasingli
clear
hostviru
interact
gener
truli
vast
yet
poorli
understood
untap
biodivers
close
special
featur
watanab
kawaoka
elabor
neovirolog
emerg
field
engag
catalogu
characteris
biodivers
global
consortium
predict
effort
unlock
vast
wealth
current
unexplor
biodivers
lead
biotechnolog
treatment
leverag
hostviru
interact
develop
throughout
evolut
biomed
innov
fall
valley
death
patient
therefor
reach
often
fall
entrust
resourc
expect
conceiv
deliv
commun
dividend
societi
cherish
eagerli
pursu
everi
stage
career
nevertheless
road
research
translat
wind
built
foundat
basic
research
support
industryacademia
collabor
nurtur
talent
skill
indopacif
region
two
four
pillar
nation
innov
scienc
agenda
frame
australia
medic
research
innov
prioriti
includ
antimicrobi
resist
global
health
health
secur
drug
repurpos
translat
research
infrastructur
captur
mani
key
element
cti
special
featur
establish
durabl
intern
relationship
integr
divers
expertis
essenti
deliv
outcom
end
nhmrc
recent
taken
step
intern
engag
strategi
increas
cooper
counterpart
oversea
includ
japan
agenc
medic
research
develop
ame
task
translat
biomed
research
output
countri
given
reciproc
effort
acceler
bilater
engag
current
underway
prospect
new
area
intern
cooper
mobil
never
excit
urgent
mind
contribut
cti
special
featur
select
research
present
fellow
invite
awaji
intern
forum
infect
immun
aifii
consortium
biolog
scienc
conbio
confer
japan
australia
japan
strong
tradit
immunolog
relat
disciplin
predict
quantiti
qualiti
import
bilater
cooper
acceler
rapidli
short
medium
term
expand
cooper
leverag
respect
research
strength
effort
may
yet
solv
mani
press
diseas
cost
sustain
issu
time
